Anti-GPRC5D-CD19-CAR-T cell therapy(The Second People Hospital Of Guangdong Province)

N/A

Report date: 2024/07/04 20:00:24

Base Information

Drug NameAnti-GPRC5D-CD19-CAR-T cell therapy(The Second People Hospital Of Guangdong Province)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionG-protein coupled receptor family C group 5member D modulatorsB-lymphocyte antigen CD19 modulatorsT lymphocyte replacements
TargetsG-protein coupled receptor family C group 5member DB-lymphocyte antigen CD19
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesThe Second People Hospital Of Guangdong Province
China Registration ClassN/A

Develop Information

Active CompaniesThe Second People Hospital Of Guangdong Province
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A